Cognoptix (fka Neuroptix) is Profiled in this Database

Updated At 08 Nov, 2013

Partial description of this company

The first early-stage, noninvasive combination drug-device diagnostic test for Alzheimer\'s disease; detects beta amyloid aggregates in the lens of the eye via a laser-based eye scanning device and an ophthalmic ointment

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Cognoptix (fka Neuroptix) plus 4750 other startups.

Start Free 7 Day Trial Now

Learn More About Cognoptix (fka Neuroptix)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy